The endpoints of a clinical trial are usually included in the study objectives. The guidance titled clinical trial endpoints for the approval of cancer drugs and biologics is the first update on this framework in more than a decade and replaces the 2007 guidance. Ovarian cancer has unique considerations for clinical trial endpoint selection. Apr, 2018 clinical significance of postprogression survival in lung cancer. Qualityoflife assessments might best be utilized in trials in which survival differences between treatments are expected to be small, which is frequently the case. It provides recommendations to applicants on endpoints for cancer clinical trials submitted to the food and.
This paper examines the key endpoints in clinical trials and u. Clinical trial endpoints for the approval of nonsmall cell lung cancer drugs and biologics april 2015. Clinical trial endpoints an endpoint is the primary outcome that is being measured by a clinical trial. Clinical trial endpoints for the approval of nonsmall cell lung cancer drugs and biologics guidance for industry u. Survival has been considered traditionally as the goldstandard endpoint for cancer clinical trials. All journal articles reporting on clinical trials will report the results in terms of the endpoints which were measured. As the ceo of a cancer therapeutics company with multiple ongoing trials in a wide range of cancers, as well as a cancer survivor myself, i have found myself drawn into this discussion and have developed a core argument as well as some complementary.
During the past 3 decades, the field of clinical research for the treatment of advanced melanoma lacked significant advances. Clinical endpoints in trials of chemoradiation for patients. This type of search will search the text, figure legends, and footnotes. Tumorcentered ous clinical endpoints tumorcentered 14,15 clinical endpoints include biological markers. Oncology endpoints in a changing landscape managed care. Appropriate endpoints in clinical trials and markers for longterm clinical outcome antonio c. Given the purpose of late phase trials is to inform clinical practice and policy, endpoints should measure outcomes which are meaningful to endusers that reflect or describe how a patient feels, functions or survives. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone. Understanding endpoints is absolutely critical to understanding the technical medical literature. Recommendations for including multiple symptoms as. Treatment clinical trials for prostate cancer national. Views on the importance of overall survival and pfs as outcome measures in trials are polarised.
Although interim analysis approaches in clinical trials are widely known, information on current practice of planned monitoring is still scarce. Improvement in signs or symptoms must clearly distinguish between tumor symptoms and drug toxicity. Study design, endpoints, and biomarkers has various searchbyword functions, and they all work perfectly. New challenges in endpoints for drug development in. Selection of endpoints for trials for regulatory purposes should be. The importance of developing a pathway for assessing tumorrelated signs and symptoms within the drugapproval process has been recognized,2 and there is increasing advocacy for the inclusion of symptom measures in cancer clinical trials. While early phase conventional clinical studies demonstrate more tangible endpoints such as tumor shrinkage, later phase endpoints may evaluate prolonged survival and quality of life. The types, frequency, and definitions of clinical primary and secondary endpoints, and patientreported outcome measures, reported in the methods and results sections of papers and protocols, if available were examined. International standards for the analysis of qualityoflife. This discussion will focus on primary endpoints for phase 3 trials. Read about safety endpoints in cancer clinical trials, including toxicity criteria in. Clinical significance of postprogression survival in lung cancer. The overwhelming majority of trials are in recurrent or metastatic prostate cancer, when patients are essentially incurable.
View the article pdf and any associated supplements and figures for a period of 48 hours. Thus, tumorcentered clinical endpoints that can be assessed earlier and used. The cancer prevention clinical trials network cpctnet performs early phase clinical trials to assess the safety, tolerability, and cancer preventive potential of agents and interventions of varying classes, many of which target molecules or processes known to be important during carcinogenesis. Approving cancer treatments based on endpoints other than overall. Ultimately, the raison detre was to expand drug development to address. Clinical trial endpoints for oncology studies applied.
Pfs is an imperfect outcome measure but is central to the design of clinical trials. At the conclusion of this module, the learner will be able to. Os results may be affected by patients crossing over from a control treatment to a new therapy during a clinical trial. Many clinical trials of targeted agents in relapsed ovarian cancer have revealed a disconnect between pfs and os outcomes that is potentially due to the disadvantages associated with each endpoint. In the treatment of cancer, endpoints can be classified into two categories. I discuss the idea of using surrogate endpoints in the context of clinical trials to compare two or more treatments or interventions in respect to some true. Clinical trial endpoints for the approval of cancer drugs and. Breast cancer, surrogate endpoint, clinical trial design, regulatory. This module will provide an overview of clinical trial design. However, benefits are often accompanied by significant symptomatic toxicities. Pdf in oncology clinical trials, many different endpoints can be used as primary or secondary endpoints. Justifying the choice of endpoints for clinical trials jnci.
Advances in cancer treatment have provided longer survival outcomes, particularly in certain. I they are usually few but are clinically most relevant to the disease and the treatment under study. Clinical trial endpoints for the approval of cancer drugs and biologics. Endpoints used in phase ii trials do not measure benefit to patients. Endpoints in neoadjuvant nonsmall cell lung cancer. Qualityoflife assessments might best be utilized in trials in which survival differences between treatments are expected to be small, which. A cancer drug, for example, might use survival as an endpoint, comparing the fiveyear survival rate of patients using an experimental therapy against the fiveyear survival rate of patients using another treatment or a placebo.
Study design, endpoints and biomarkers, drug safety, and fda and ich guidelines is a practical guidebook for those engaged in clinical trial design. In principle, there are two general categories of endpoints in clinical trials. Pdf endpoints in oncology clinical trials researchgate. This productive discourse culminated in the fda hosting a clinical trial endpoints in ovarian cancer workshop in 2015. May 21, 2008 when selecting endpoints in hcc clinical trials, researchers should give specific consideration to the fact that death often occurs as a result of liver failure in patients with liver cancer.
Justifying the choice of endpoints for clinical trials. Fred hutchinson cancer research center, 1124 columbia street, seattle, wa 98104, u. Outcomes and endpoints in trials of cancer treatment the lancet. Evaluation of the true endpoint of clinical trials for. Adapted from matulonis and colleagues 17 with permission from the american cancer society. Missing pro data is an ongoing challenge in cancer clinical trials, as patients drop out of a study for different reasons, including predefined progression of disease, death, intolerable toxicity, and patient or clinician decision. This book details the organizations and content of clinical trials, including trial design, safety, endpoints, subgroups, hrqol, consent forms and package inserts. Adjusting for multiplicity in clinical trials composite. The clinical trials on this list are for prostate cancer treatment. In oncology, pfs is an intermediate endpoint that is relevant on its own right. Available drugs had low antitumor activity and no proven benefit in overall survival. Cancer clinical trials have relied on overall survival and measures of tumor growth or reduction to assess the efficacy of a drug. Each of these endpoints is associated with certain advantages and limitations.
Selection of endpoints for trials for regulatory purposes should be discussed with the fda prior to the initiation of the clinical trial. Apr 27, 2015 in the debate over patientcentric considerations in cancer care, one main focus has been the choice of proper endpoints for clinical trials. Unfortunately, only a fraction of clinical trials for new therapies are conducted in patients presenting with localized disease. In oncology clinical trials, many different endpoints can be. Nov 12, 2019 optimisation and selection of endpoints for clinical trials is an evolving field. Clinical trials are research studies that involve people. Clinical trial safety endpoints biooncology this website is intended for us healthcare professionals only. The dearth of trials in early prostate cancer stems from the difficulty in conducting them. Prentice fred hutchinson cancer research center, 1124 columbia street, seattle, wa 98104, u. The eunethta draft guideline on clinical endpoints is a work in progress, the. Department of health and human services food and drug administration. Clinical trial endpoints friends of cancer research. Focusing on core patientreported outcomes in cancer. Design and endpoints of clinical trials in hepatocellular.
Endpoints in neoadjuvant nonsmall cell lung cancer clinical. Appropriately designed and analyzed trials can establish an effect of the drug on something. Clinical trial endpoints for the approval of cancer drugs. The most common and most meaninfgul clinical endpoint in cancer research is overall survival. Although the endpoint definitions provided here are from fda guidance, please note that individual clinical trials may use different definitions. Since recistwas published in 2000, many investigators, cooperative groups, industry and government authorities have adopted these criteria in the assessment of treatment outcomes. Recently, new drugs developed based on an indepth understanding of the biology of this disease have shown significant benefit, with ipilimumab and vemurafenib having recently shown a. Clinical endpoints are measured in clinical trials or other types of studies. This tradition is congruent with the historical requirement of the us food and drug administration fda that improvement in either survival or meaningful clinical benefit, such as amelioration of major symptoms, is needed to justify marketing approval of a new drug. Optimisation and selection of endpoints for clinical trials is an evolving field. Innovative clinical trial endpoints are intended to evaluate potential new cancer treatments. Recommendations for including multiple symptoms as endpoints.
Cancer treatment should allow patients to live better or longer lives, and ideally, both. Recently, new drugs developed based on an in depth understanding of the biology of this disease have shown significant benefit, with ipilimumab and vemurafenib having recently shown a. Clinical trial endpoints for the approval of non small. New challenges in endpoints for drug development in advanced. Therapy in operable breast cancer pst may allow trials that target various breast cancer subtypes and that rely. I primary endpoints address primary objectives of the trial. Choosing primary endpoints for clinical trials of health. Patientcentered clinical endpoints are variables that reflect a patients feeling of wellbeing or his survival 1. Trial endpoints should show clinically meaningful improvements in patient survival or quality of life. Endpoint selection in ovarian cancer clinical trials should reflect the impact on. Clinical trials, end points, and statisticsmeasuring and. Are we making progress in assessing progression in cancer clinical trials.
Choosing primary endpoints for clinical trials of health care. Adjusting for multiplicity in clinical trials composite and secondary endpoints abdul j. The degree to which a therapy improves disease symptoms and introduces symptomatic toxicity affects how patients function in their daily lives. Fda ovarian cancer clinical trial endpoints workshop. Fda issues new framework for oncology drug development. Recommendations of the prostate cancer clinical trials working group howard i. In cancer clinical trials, the patientreported outcomes are increasingly used to analyze a clinical benefit for medical decisionmaking fiteni et al. Endpoints for assessing drug activity in clinical trials. Assessing endpoints in oncology clinical trials steven hirschfeld, md phd office of cellular, tissue and gene therapy center for biologics evaluation and research.
Scher, susan halabi, ian tannock, michael morris, cora n. In oncology clinical trials, many different endpoints can be used as primary or secondary endpoints. Clinical trial endpoints for the approval of cancer drugs and biologics guidance for industry december 2018. Di erent types of endpoints clinical trials generally classify the endpoints into primary, secondary and exploratory types. Design and end points of clinical trials for patients with. Reports of studies rarely include details on the strategies for both data monitoring and interim analysis. Evaluation of the true endpoint of clinical trials for cancer. Commonly used efficacy endpoints in oncology clinical trials. A surrogate endpoint is a substitute for a clinical endpoint used in trials where the use of a clinical endpoint might not be possible or practical if, for example, a drugs direct benefits would take. Progressionfree survival pfs is used commonly as a primary endpoint in phase iii trials evaluating treatment of metastatic cancer.
Alternative endpoints such as progressionfree survival, diseasefree survival, and objective response rate have been used to identify benefit earlier, but their true validity as surrogate endpoints is. Adjusting for multiplicity in clinical trials composite and. Although the authors of that study suggested better enforcement of. The following table shows a number of efficacy endpoints. Clinical trials are designed to identify one factor as the most important goal for. International standards for the analysis of qualityof. Oncologists use the term endpoint to refer to an outcome they are trying to measure with a clinical trial. In the debate over patientcentric considerations in cancer care, one main focus has been the choice of proper endpoints for clinical trials. Discuss the objectives, endpoints and standard design for phase i, ii, and iii clinical trials.
When selecting endpoints in hcc clinical trials, researchers should give specific consideration to the fact that death often occurs as a result of liver failure in patients with liver cancer. Stakeholders invited to participate included the american association for cancer research aacr, american society of clinical oncology asco, patient advocates, and sgo. The aim of this project is to investigate the forms of monitoring used in cancer clinical trials and in particular to gather information on the. Clinical trial endpoints for the approval of nonsmall.
Outcomes and endpoints in trials of cancer treatment. Given the purpose of late phase trials is to inform clinical practice and policy, endpoints should measure outcomes which are meaningful to endusers that reflect or. These are considered in the context that standard endpoints already exist in cancer clinical trials and have served us well. These searchbyword functions include the following. Definition of endpoint nci dictionary of cancer terms. Chapter 4 analysis of multiple endpoints in clinical trials. With the fda and pharmaceutical industry prioritizing faster and more efficient oncology drug development, the use of surrogate endpoints may be a valuable alternative to traditional survival endpoints, particularly in nonsmall cell lung cancer nsclc. Safety endpoints in cancer clinical trials biooncology.
1223 1295 916 89 552 660 578 1221 800 1119 796 347 485 440 1276 978 999 745 989 34 660 375 499 517 646 1493 898 261 1386 290 808 156 19 615 138 835 58 742 1009 912 1440 1141 515 1021